These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 34225013)

  • 1. Emerging application of metabolomics on Chinese herbal medicine for depressive disorder.
    Gu X; Gao X; Cheng J; Xia C; Xu Y; Yang L; Zhou M
    Biomed Pharmacother; 2021 Sep; 141():111866. PubMed ID: 34225013
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Dynamic analysis of the endogenous metabolites in depressed patients treated with TCM formula Xiaoyaosan using urinary (1)H NMR-based metabolomics.
    Tian JS; Peng GJ; Gao XX; Zhou YZ; Xing J; Qin XM; Du GH
    J Ethnopharmacol; 2014 Dec; 158 Pt A():1-10. PubMed ID: 25448502
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Plasma-metabolite-biomarkers for the therapeutic response in depressed patients by the traditional Chinese medicine formula Xiaoyaosan: A (1)H NMR-based metabolomics approach.
    Liu CC; Wu YF; Feng GM; Gao XX; Zhou YZ; Hou WJ; Qin XM; Du GH; Tian JS
    J Affect Disord; 2015 Oct; 185():156-63. PubMed ID: 26186531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Metabolic Factors and Adult Neurogenesis: Impacts of Chinese Herbal Medicine on Brain Repair in Neurological Diseases.
    Gao C; Shen J
    Int Rev Neurobiol; 2017; 135():117-147. PubMed ID: 28807156
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Neurobiology of Chinese Herbal Medicine on Major Depressive Disorder.
    Chen G; Guo X
    Int Rev Neurobiol; 2017; 135():77-95. PubMed ID: 28807166
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Plasma metabolomics of depressed patients and treatment with Xiaoyaosan based on mass spectrometry technique.
    Liu X; Liu C; Tian J; Gao X; Li K; Du G; Qin X
    J Ethnopharmacol; 2020 Jan; 246():112219. PubMed ID: 31494201
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and safety of Chinese herbal medicine for depression: A systematic review and meta-analysis of randomized controlled trials.
    Wang Y; Shi YH; Xu Z; Fu H; Zeng H; Zheng GQ
    J Psychiatr Res; 2019 Oct; 117():74-91. PubMed ID: 31326751
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Metabolomics: towards understanding traditional Chinese medicine.
    Zhang A; Sun H; Wang Z; Sun W; Wang P; Wang X
    Planta Med; 2010 Dec; 76(17):2026-35. PubMed ID: 21058239
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Anti-depressive effects of Kai-Xin-San on lipid metabolism in depressed patients and CUMS rats using metabolomic analysis.
    Zhou X; Wang J; Lu Y; Chen C; Hu Y; Liu P; Dong X
    J Ethnopharmacol; 2020 Apr; 252():112615. PubMed ID: 31991203
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Association between Chinese herbal medicine (CHM) treatment and depression among cancer patients in China: An outpatient-based cross-sectional study.
    Lin H; Zhang X; Zhang Y; Cui W; Jia F; Wang J
    Medicine (Baltimore); 2023 Aug; 102(34):e34695. PubMed ID: 37653736
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Studies on the potential link between antidepressant effect of Xiaoyao San and its pharmacological activity of hepatoprotection based on multi-platform metabolomics.
    Chen C; Yin Q; Tian J; Gao X; Qin X; Du G; Zhou Y
    J Ethnopharmacol; 2020 Mar; 249():112432. PubMed ID: 31790818
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Chinese herbal medicine for the treatment of intestinal cancer: preclinical studies and potential clinical applications.
    Zhang J; Wu Y; Tian Y; Xu H; Lin ZX; Xian YF
    Mol Cancer; 2024 Oct; 23(1):217. PubMed ID: 39354520
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Associating 197 Chinese herbal medicine with drug targets and diseases using the similarity ensemble approach.
    Gu S; Lai LH
    Acta Pharmacol Sin; 2020 Mar; 41(3):432-438. PubMed ID: 31530902
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An NMR metabolomics investigation of perturbations after treatment with Chinese herbal medicine formula in an experimental model of sepsis.
    Li Y; Liu H; Wu X; Li D; Huang J
    OMICS; 2013 May; 17(5):252-8. PubMed ID: 23594183
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Integrated network pharmacology and metabolomics to dissect the combination mechanisms of Bupleurum chinense DC-Paeonia lactiflora Pall herb pair for treating depression.
    Li X; Qin XM; Tian JS; Gao XX; Du GH; Zhou YZ
    J Ethnopharmacol; 2021 Jan; 264():113281. PubMed ID: 32810624
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Q-marker screening strategy based on ADME studies and systems biology for Chinese herbal medicine, taking Qianghuo Shengshi decoction in treating rheumatoid arthritis as an example.
    Wang J; Tao C; Xu G; Ling J; Tong J; Goh BH; Xu Y; Qian L; Chen Y; Liu X; Wu Y; Xu T
    Mol Omics; 2023 Dec; 19(10):769-786. PubMed ID: 37498608
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Chinese herbal medicine-derived compounds for cancer therapy: a focus on hepatocellular carcinoma.
    Hu Y; Wang S; Wu X; Zhang J; Chen R; Chen M; Wang Y
    J Ethnopharmacol; 2013 Oct; 149(3):601-12. PubMed ID: 23916858
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Effects of Chinese herbal medicines on dementia risk in patients with sleep disorders in Taiwan.
    Chen CJ; Liu X; Chiou JS; Hang LW; Li TM; Tsai FJ; Ko CH; Lin TH; Liao CC; Huang SM; Liang WM; Lin YJ
    J Ethnopharmacol; 2021 Jan; 264():113267. PubMed ID: 32822822
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chinese herbal medicine for Alzheimer's disease: Clinical evidence and possible mechanism of neurogenesis.
    Yang WT; Zheng XW; Chen S; Shan CS; Xu QQ; Zhu JZ; Bao XY; Lin Y; Zheng GQ; Wang Y
    Biochem Pharmacol; 2017 Oct; 141():143-155. PubMed ID: 28690138
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Alteration of Amino Acid Profiling Influenced by the Active Ingredients of DanHong Injection After Prescription Optimization.
    Guo Z; Zhu Y; Xu W; Luo K; Xiao H; Wang Z
    Drug Des Devel Ther; 2019; 13():3939-3947. PubMed ID: 31819368
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.